Literature DB >> 7079575

Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis.

J C Robin, J L Ambrus.   

Abstract

Neutron activation analysis was employed to determine total body calcium in C3H/St (Ha) female mice. Ninty-nine percent of total body calcium is in bone and loss of calcium was used as an index of osteoporosis. Heparin (500 U/kg B.I.D.) treatment for three months resulted in significant osteoporosis. Both human and salmon calcitonin (4 MRC U/Kg B.I.D.) prevented heparin induced osteoporosis. The results suggest that calcitonin may prevent pathological fractures in patients on anticoagulants and other osteoporosis inducing regimens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7079575

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  3 in total

Review 1.  Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

Review 2.  Effects of calcitonin on bone quality and osteoblastic function.

Authors:  S Wallach; J R Farley; D J Baylink; L Brenner-Gati
Journal:  Calcif Tissue Int       Date:  1993-05       Impact factor: 4.333

3.  Dihydrocaffeic Acid-Decorated Iron Oxide Nanomaterials Effectively Inhibit Human Calcitonin Aggregation.

Authors:  Cai-Ling Shen; Yu-Hsuan Wu; Ting-Hao Zhang; Ling-Hsien Tu
Journal:  ACS Omega       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.